| pubmed-article:8324843 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:8324843 | lifeskim:mentions | umls-concept:C0034693 | lld:lifeskim |
| pubmed-article:8324843 | lifeskim:mentions | umls-concept:C0005682 | lld:lifeskim |
| pubmed-article:8324843 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
| pubmed-article:8324843 | lifeskim:mentions | umls-concept:C0940937 | lld:lifeskim |
| pubmed-article:8324843 | lifeskim:mentions | umls-concept:C0021469 | lld:lifeskim |
| pubmed-article:8324843 | lifeskim:mentions | umls-concept:C0073102 | lld:lifeskim |
| pubmed-article:8324843 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:8324843 | pubmed:dateCreated | 1993-8-12 | lld:pubmed |
| pubmed-article:8324843 | pubmed:abstractText | The model of precancerous lesions of the bladder in rats was induced by N-butyl-(4-hydroxybutyl) nitrosamide (BBN). The animals were randomly divided into the following 3 groups: 1) given Antitumor-B (Chinese herbs); 2) given 4-ethoxycarbophenylretinamide (Retinamide); and 3) control. After treatment for 13 months the rats were killed for pathomorphological examination of the bladder. The results showed that the incidence of bladder cancer in group 1 and 2 was reduced by 90.7% (P < 0.01) and 75.0% (P < 0.01) respectively after treatment as compared with the control group. Our results provide a useful reference for clinical trial in the prevention of bladder cancer recurrence by using antitumor-B and Retinamide. | lld:pubmed |
| pubmed-article:8324843 | pubmed:language | chi | lld:pubmed |
| pubmed-article:8324843 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8324843 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:8324843 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8324843 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8324843 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8324843 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8324843 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8324843 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8324843 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:8324843 | pubmed:month | Feb | lld:pubmed |
| pubmed-article:8324843 | pubmed:issn | 1000-503X | lld:pubmed |
| pubmed-article:8324843 | pubmed:author | pubmed-author:FaeAA | lld:pubmed |
| pubmed-article:8324843 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:8324843 | pubmed:volume | 15 | lld:pubmed |
| pubmed-article:8324843 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:8324843 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:8324843 | pubmed:pagination | 71-3 | lld:pubmed |
| pubmed-article:8324843 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:8324843 | pubmed:meshHeading | pubmed-meshheading:8324843-... | lld:pubmed |
| pubmed-article:8324843 | pubmed:meshHeading | pubmed-meshheading:8324843-... | lld:pubmed |
| pubmed-article:8324843 | pubmed:meshHeading | pubmed-meshheading:8324843-... | lld:pubmed |
| pubmed-article:8324843 | pubmed:meshHeading | pubmed-meshheading:8324843-... | lld:pubmed |
| pubmed-article:8324843 | pubmed:meshHeading | pubmed-meshheading:8324843-... | lld:pubmed |
| pubmed-article:8324843 | pubmed:meshHeading | pubmed-meshheading:8324843-... | lld:pubmed |
| pubmed-article:8324843 | pubmed:meshHeading | pubmed-meshheading:8324843-... | lld:pubmed |
| pubmed-article:8324843 | pubmed:meshHeading | pubmed-meshheading:8324843-... | lld:pubmed |
| pubmed-article:8324843 | pubmed:meshHeading | pubmed-meshheading:8324843-... | lld:pubmed |
| pubmed-article:8324843 | pubmed:meshHeading | pubmed-meshheading:8324843-... | lld:pubmed |
| pubmed-article:8324843 | pubmed:year | 1993 | lld:pubmed |
| pubmed-article:8324843 | pubmed:articleTitle | [Inhibitory effect of antitumor-B and retinamide on precancerous lesions of the bladder in rats]. | lld:pubmed |
| pubmed-article:8324843 | pubmed:affiliation | Institute of Oncology, Beijing. | lld:pubmed |
| pubmed-article:8324843 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:8324843 | pubmed:publicationType | English Abstract | lld:pubmed |
